Syndesi Therapeutics clinical trials
Acquired by AbbVie, Mar 1, 2022 · source ↗
The registry lists 2 studies whose lead sponsor is Syndesi Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 22, 2022.
Before and after it joined AbbVie
- First submitted before Syndesi Therapeutics became part of AbbVie
- 2
- First submitted after Syndesi Therapeutics became part of AbbVie
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Syndesi Therapeutics2 studies
Something wrong with this grouping? Tell us on the AbbVie page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All AbbVie studies →
- A Study of SDI-118 in Participants in Remission From DepressionWithdrawnNCT05212116Phase 1
Sponsor listed in the registry: Syndesi Therapeutics · First submitted before Syndesi Therapeutics became part of AbbVie
- A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SDI-118 in Elderly Male and Female Study Participants With Cognitive DeclineTerminatedNCT05199142Phase 1
Sponsor listed in the registry: Syndesi Therapeutics · First submitted before Syndesi Therapeutics became part of AbbVie